11/20
06:00 am
tbph
Theravance Biopharma to Participate in an Upcoming Investor Conference
Low
Report
Theravance Biopharma to Participate in an Upcoming Investor Conference
11/19
08:20 am
tbph
Kevin Krause named President and CEO of ArrePath [Yahoo! Finance]
Medium
Report
Kevin Krause named President and CEO of ArrePath [Yahoo! Finance]
11/13
02:32 am
tbph
Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
Medium
Report
Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
11/12
10:48 pm
tbph
Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call Transcript [Seeking Alpha]
11/12
04:14 pm
tbph
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value [Yahoo! Finance]
Medium
Report
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value [Yahoo! Finance]
11/12
04:05 pm
tbph
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
Medium
Report
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
11/11
09:37 am
tbph
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance [Yahoo! Finance]
Low
Report
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance [Yahoo! Finance]
11/11
07:33 am
tbph
What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings [Yahoo! Finance]
10/24
06:00 am
tbph
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
Low
Report
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
10/18
09:00 am
tbph
Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
Low
Report
Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
9/16
08:03 am
tbph
Theravance Biopharma, Inc. (NASDAQ: TBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Theravance Biopharma, Inc. (NASDAQ: TBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
9/6
10:57 am
tbph
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation [Yahoo! Finance]
8/27
06:00 am
tbph
Theravance Biopharma to Participate in an Upcoming Investor Conference
Low
Report
Theravance Biopharma to Participate in an Upcoming Investor Conference